Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

Research and Innovation Action · Running

CoMPaSS-NMD Computational Models for new Patients Stratification Strategies of Neuromuscular Disorders

Coordinator
Universita Degli Studi Di Modena E Reggio Emilia, Italy
Runs
1 May 2023 to 30 April 2027
Status
Running
EU funding
€5.0m
Total cost
€5.0m
Partners
12 organisations in 8 countries
Type
Research and Innovation Action
Grant agreement
101080874

What the project is doing

In the project's own words, from its summary on CORDIS.

The CoMPaSS-NMD project creates novel and universal tools for the diagnostic stratification of patients suffering from Hereditary NeuroMuscular Diseases (HNMDs) aiming at personalised treatments. HNMDs often occurs in young people, causing long-term disability and early death; these conditions bring lack of participation, need for permanent assistance and may require long-term institutionalisation. Multidimensional HNMD data - clinical, genetic, histopathological and MRI – will be provided by third-level clinical centers in Italy, France, Germany, Finland and the United Kingdom as part of the European Reference Network for Rare Neurological Diseases.

Computational tools for high-dimensional clustering will be applied in an unsupervised learning approach using the internal structure of data to define groups of similar patients. Classification model averaging and integration techniques for federated learning-inspired model building and novel HNMD-specific descriptors of histopathological images will be implemented. The adoption of this multidimensional view has the potential to increment the diagnostic rate of HNMDs by 30% and foster effective actions by European national health systems.

As main project outcome, the CoMPaSS-NMD Atlas Platform will be a cost-effective AI-based application providing precise clinical characterization and diagnosis, with data remaining publicly available for anyone in the research and health community to use. The project will deliver Recommendations and Guidelines for stratification-based patient management to offer superior standard-of-care for diagnosis and prognosis and assist in planning clinical trials.

It will follow a user-centred, co-design methodology with a strong stakeholder engagement and networking with other project consortia. The project engages partners with clinical, biotechnological, ICT, AI, ethical and legal, communication and exploitation competences: 6 clinical/academic centres, 1 academic, 4 industrial partners.

Who is involved

OrganisationCityCountryRole
Universita Degli Studi Di Modena E Reggio EmiliaModenaItalyCoordinator
Fincons Group AGKussnachtSwitzerlandAssociatedpartner
Cegat GmbHTubingenGermanyParticipant
Klinikum Der Ludwig-Maximilians-Universitat MunchenMunchenGermanyThird party
Ludwig-Maximilians-Universitaet MuenchenPlaneggGermanyParticipant
Fundacion Tecnalia Research & InnovationDonostia/San SebastianSpainParticipant
Samfundet Folkhalsan I Svenska Finland RfHelsinkiFinlandParticipant
Centre Europeen De Recherche En Biologie Et En MedecineIllkirch CedexFranceParticipant
Deep Blue SRLRomaItalyParticipant
Fondazione Stella MarisPisaItalyParticipant
Politechnika SlaskaGliwicePolandParticipant
University of Newcastle Upon TyneNewcastle Upon TyneUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI